PMID: 786662Mar 22, 1976Paper

A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol

European Journal of Clinical Pharmacology
L HanssonB Karlberg

Abstract

Propranolol was given to 30 patients with essential hypertension following randomised, double-blind administration of either placebo or a new cardioselective beta-adrenergic receptor antagonist, atenolol (Tenormin, ICI 66 082). Both atenolol and propranolol caused statistically significant reduction of recumbent and erect blood pressure and heart rate. There were no important differences between these variables on comparison of atenolol and propranolol.

References

May 17, 1975·British Medical Journal·L HanssonA Westerlund
Sep 20, 1973·The American Journal of Cardiology·P Kincaid-Smith
Jan 1, 1974·Naunyn-Schmiedeberg's Archives of Pharmacology·K H RahnG Planz
Apr 1, 1972·Klinische Wochenschrift·L HanssonB Hood
Jun 1, 1972·American Heart Journal·F J ZachariasB G Wall
Mar 1, 1968·Circulation·E D FrohlichI H Page
Jan 4, 1969·British Medical Journal·B N PRICHARD, P M GILLAM
Mar 1, 1964·Clinical Pharmacology and Therapeutics·G SCHROEDER, L WERKOE
Sep 19, 1964·British Medical Journal·B N PRICHARD, P M GILLAM

Citations

Jan 1, 1976·European Journal of Clinical Pharmacology·R H BergstrandG Berglund
Nov 16, 1978·European Journal of Clinical Pharmacology·A MelanderN O Sjöberg
Jan 1, 1990·Pharmacology & Therapeutics·J McAinsh, J M Cruickshank

Related Concepts

Antihypertensive Agents
Tenormin
Diastolic Blood Pressure
Clinical Trials
Pulse Rate
Hypertensive Disease
Placebos
Propanolamines
Rexigen

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.